Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Advances in Therapy|July 9, 2020
Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of ChoiceSebastian Haferkamp, Mareike Alter, Dirk Debus, et al.
International Journal of Cancer|December 1, 2015
Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and humanLisa Andzinski, Nadine Kasnitz, Stephanie Stahnke, et al.
Plos One|November 22, 2013
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinomaKlaus G Griewank, Rajmohan Murali, Bastian Schilling, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 5, 2023
Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center studyAgmal Scherzad, Manuel Stöth, Till J Meyer, et al.
The British Journal of Dermatology|September 4, 2025
Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma - Results of a multicenter phase II studySebastian Haferkamp, Bastian Schilling, Carola Berking, et al.
Acta Dermato-Venereologica|January 20, 2026
Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective StudySimon Goller, Tassilo Dege, Patrick Schummer, et al.
Plos One|April 22, 2015
Corticosteroids augment BRAF inhibitor vemurafenib induced lymphopenia and risk of infectionWiebke Sondermann, Klaus G Griewank, Bastian Schilling, et al.
Cancers|October 14, 2022
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant MelanomaNora Isberner, Anja Gesierich, David Balakirouchenane, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitisCindy Franklin, Isabelle Rooms, Melanie Fiedler, et al.
Frontiers in Oncology|April 1, 2021
Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic BoundariesAndré Marquardt, Antonio Giovanni Solimando, Alexander Kerscher, et al.
Pageof 17